D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 51 Citations 10,170 100 World Ranking 2596 National Ranking 1251

Overview

What is he best known for?

The fields of study he is best known for:

  • Virus
  • Antibody
  • Immune system

His primary scientific interests are in Virology, Coronavirus, Antibody, Middle East respiratory syndrome coronavirus and Receptor. Lanying Du performs multidisciplinary study on Virology and Middle East respiratory syndrome in his works. His Antibody study is focused on Immunology in general.

His Immune system study in the realm of Immunology interacts with subjects such as Social stability. The various areas that Lanying Du examines in his Receptor study include Haplorhini, RNA interference, Viral structural protein and Microbiology. His Viral Vaccine research incorporates themes from HEK 293 cells, Plasma protein binding, Antiserum and Binding site.

His most cited work include:

  • The spike protein of SARS-CoV — a target for vaccine and therapeutic development (791 citations)
  • Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. (631 citations)
  • Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. (477 citations)

What are the main themes of his work throughout his whole career to date?

Lanying Du spends much of his time researching Virology, Antibody, Coronavirus, Virus and Immunology. His Virology research includes elements of Immune system and Immunogenicity. His studies deal with areas such as Viral replication and Vaccination as well as Immune system.

His Antibody research is multidisciplinary, incorporating elements of Adjuvant and Antigen. His biological study spans a wide range of topics, including Spike Protein and Severe acute respiratory syndrome coronavirus 2. His Middle East respiratory syndrome coronavirus research incorporates elements of Middle East respiratory syndrome and Coronavirus Infections.

He most often published in these fields:

  • Virology (81.94%)
  • Antibody (36.11%)
  • Coronavirus (34.03%)

What were the highlights of his more recent work (between 2019-2021)?

  • Virology (81.94%)
  • Severe acute respiratory syndrome coronavirus 2 (11.81%)
  • Coronavirus (34.03%)

In recent papers he was focusing on the following fields of study:

Lanying Du focuses on Virology, Severe acute respiratory syndrome coronavirus 2, Coronavirus, Antibody and 2019-20 coronavirus outbreak. Lanying Du incorporates Virology and Pneumonia in his research. His Severe acute respiratory syndrome coronavirus 2 research integrates issues from Middle East respiratory syndrome coronavirus and Pandemic.

His research investigates the connection between Coronavirus and topics such as Coronavirus Infections that intersect with issues in Human coronavirus and Betacoronavirus. His Antibody research includes themes of Adjuvant, In vitro, Immune system and Drug. As a part of the same scientific family, he mostly works in the field of 2019-20 coronavirus outbreak, focusing on Monoclonal antibody and, on occasion, Cross neutralization, Epitope and Antigen.

Between 2019 and 2021, his most popular works were:

  • Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. (631 citations)
  • Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. (477 citations)
  • Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses. (378 citations)

In his most recent research, the most cited papers focused on:

  • Virus
  • Antibody
  • Immune system

His main research concerns Coronavirus, Severe acute respiratory syndrome coronavirus 2, Virology, Antibody and 2019-20 coronavirus outbreak. His study of Coronavirus brings together topics like Nucleic acid amplification technique, Rhinovirus, Respiratory tract infections and Respiratory virus. Lanying Du combines subjects such as Middle East respiratory syndrome coronavirus and Severe acute respiratory syndrome coronavirus with his study of Severe acute respiratory syndrome coronavirus 2.

His Virology study frequently draws connections to other fields, such as Cell fusion. His Antibody study combines topics from a wide range of disciplines, such as HEK 293 cells, Receptor and Plasma protein binding. His Outbreak study integrates concerns from other disciplines, such as Unknown aetiology, Environmental health and Intensive care medicine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The spike protein of SARS-CoV — a target for vaccine and therapeutic development

Lanying Du;Yuxian He;Yusen Zhou;Shuwen Liu.
Nature Reviews Microbiology (2009)

1066 Citations

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.

Wanbo Tai;Lei He;Xiujuan Zhang;Jing Pu;Jing Pu.
Cellular & Molecular Immunology (2020)

801 Citations

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.

Shuai Xia;Meiqin Liu;Chao Wang;Wei Xu.
Cell Research (2020)

745 Citations

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.

Shibo Jiang;Shibo Jiang;Christopher Hillyer;Lanying Du.
Trends in Immunology (2020)

486 Citations

Molecular mechanism for antibody-dependent enhancement of coronavirus entry

Yushun Wan;Jian Shang;Shihui Sun;Wanbo Tai.
Journal of Virology (2019)

449 Citations

Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor

Lu Lu;Qi. Liu;Yun Zhu;Kwok-Hung Chan.
Nature Communications (2014)

347 Citations

Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China.

Fei Yu;Lanying Du;David M. Ojcius;Chungen Pan.
Microbes and Infection (2020)

289 Citations

Recent advances in the detection of respiratory virus infection in humans

Naru Zhang;Lili Wang;Xiaoqian Deng;Ruiying Liang.
Journal of Medical Virology (2020)

256 Citations

Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus

Yang Yang;Lanying Du;Chang Liu;Lili Wang.
Proceedings of the National Academy of Sciences of the United States of America (2014)

236 Citations

An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies

Shibo Jiang;Shibo Jiang;Lanying Du;Zhengli Shi.
Emerging microbes & infections (2020)

232 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Lanying Du

Shibo Jiang

Shibo Jiang

Fudan University

Publications: 122

Ralph S. Baric

Ralph S. Baric

University of North Carolina at Chapel Hill

Publications: 57

Lu Lu

Lu Lu

Fudan University

Publications: 56

Kwok-Yung Yuen

Kwok-Yung Yuen

University of Hong Kong

Publications: 49

Shuwen Liu

Shuwen Liu

Southern Medical University

Publications: 42

George F. Gao

George F. Gao

Chinese Center For Disease Control and Prevention

Publications: 34

M. Alejandra Tortorici

M. Alejandra Tortorici

University of Washington

Publications: 31

Bart L. Haagmans

Bart L. Haagmans

Erasmus University Rotterdam

Publications: 30

Patrick C. Y. Woo

Patrick C. Y. Woo

University of Hong Kong

Publications: 29

Jason S. McLellan

Jason S. McLellan

The University of Texas at Austin

Publications: 27

Maria Elena Bottazzi

Maria Elena Bottazzi

Baylor College of Medicine

Publications: 27

Berend Jan Bosch

Berend Jan Bosch

Utrecht University

Publications: 27

Stanley Perlman

Stanley Perlman

University of Iowa

Publications: 25

Dimiter S. Dimitrov

Dimiter S. Dimitrov

University of Pittsburgh

Publications: 24

Susanna K. P. Lau

Susanna K. P. Lau

University of Hong Kong

Publications: 24

Barney S. Graham

Barney S. Graham

National Institutes of Health

Publications: 24

Trending Scientists

Brian D. Davison

Brian D. Davison

Lehigh University

Ali Hortacsu

Ali Hortacsu

University of Chicago

Claudio Landim

Claudio Landim

Instituto Nacional de Matemática Pura e Aplicada

Kun Wang

Kun Wang

University of California, Los Angeles

Jason C. S. Woo

Jason C. S. Woo

University of California, Los Angeles

Qiang Cui

Qiang Cui

Boston University

Gary K. Ackers

Gary K. Ackers

Washington University in St. Louis

Qixing Zhou

Qixing Zhou

Nankai University

Jens Mühle

Jens Mühle

University of California, San Diego

Pierre-Emmanuel Kirstetter

Pierre-Emmanuel Kirstetter

University of Oklahoma

Thomas Werfel

Thomas Werfel

Hannover Medical School

Ira J. Goldberg

Ira J. Goldberg

New York University

Matcheri S. Keshavan

Matcheri S. Keshavan

Beth Israel Deaconess Medical Center

Daniel Sperling

Daniel Sperling

University of Haifa

Raymond Hinnebusch

Raymond Hinnebusch

University of St Andrews

Ralph Blumenhagen

Ralph Blumenhagen

Max Planck Society

Something went wrong. Please try again later.